Home › Medulloblastoma › Florida
Pag-aaral pangklinika para sa Medulloblastoma sa Florida
6 pag-aaral para sa Medulloblastoma ang naghahanap ng mga kalahok sa mga site sa Florida.
Mga Lungsod sa Florida
Opisyal na teksto ng pag-aaral (English)
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Orlando Health Arnold Palmer Hospital for Children, Orlando
- St. Joseph's Children's Hospital, Tampa
Nagre-recruitPhase 2
59 Months · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05535166Digoxin Medulloblastoma Study
- Nemours Jacksonville, Jacksonville
- University of Miami, Miami
- Johns Hopkins All Children's, St. Petersburg
- at 1 pa
Nagre-recruitPhase 2
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
- Nemours Children's Clinic-Jacksonville, Jacksonville
- at 7 pa
Nagre-recruitPhase 3
Edad 4 hanggang 21 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Nicklaus Children's Hospital, Miami
Nagre-recruitPhase 2
Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05096481DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- All Children's Hospital Johns Hopkins Medicine, St. Petersburg
- at 1 pa
Nagre-recruitPhase 2
Hanggang edad 21 · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT04696029Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
- University of Florida Health, Gainesville
Nagre-recruitPhase 1
Edad 4 hanggang 30 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06514898Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.